Position in SRPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
5 quarters on record
Derivatives in SRPT
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$3,856,362
PutShares
214,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WHITEBOX ADVISORS LLC holds $208,093,702 across 8 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
2,100,001 | $148,365,070 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
450,001 | $59,728,632 | |
| 3 | ESLA |
Estrella Immunopharma, Inc.
|
42,293 | $0 | |
| 4 | 275,001 | $0 | |||
| 5 | ASBP |
Aspire Biopharma Holdings, Inc.
|
118,750 | $0 | |
| 6 | TVGN |
Tevogen Inc.
|
86,292 | $0 | |
| 7 | VRXA |
Veraxa Biotech AG - Post de-SPAC
|
193,612 | $0 | |
| 8 | DRTS |
Alpha Tau Medical Ltd.
|
136,018 | $0 |
All Filings in SRPT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,856,362 | 214,600 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $4,669,696 | 214,600 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $17,448,416 | 810,800 | Put | Sole | 2026-02-17 | |
| 2025-09-30 | $15,624,116 | 810,800 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $12,219,660 | 714,600 | Put | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||